Moreover, the elevated expression of KLHL5 was significantly correlated with a favorable OS (HR 0.77, 95% CI 0.61–0.92, P = 0.033) but had no effect on PFS (HR 1.17, 95% CI 0.94–1.46, P = 0.17) in ovarian cancer patients (Figures 2O, P). The gene discussed is KLHL5; the disease is ovarian carcinoma.